WithdrawnNCT02233829
Dopamine Rhythms in Health and Addiction
Medication studyAges 21–55United States
Understand this study
Who could participate?
Listed age limits: 21 years to 55 years.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 23, 2024
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug, Radiation
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 21 Years to 55 Years
- Official registry ID
- NCT02233829
- Official title
Show the full official title
Dopamine Rhythms in Health and Addiction
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), a research institute.
Does this study involve medication?
Yes. The study involves medication, including Brain Dopamine Reactivity.
Who can participate?
Listed age limits: 21 years to 55 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
